Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01886170 · ClinicalTrials.gov registry record · NA

Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes

A NA study of Diabetes, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT01886170 is a NA study of Diabetes that has completed, run by University of Pennsylvania. The registered enrollment target is 200 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01886170, a NA study of Diabetes, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

In this two-phase mixed methods study, the investigators will first use patient feedback from semi-structured interviews to explore the ways in which patients with diabetes understand their diabetes and assess their disease control. The investigators will also use these interviews to elicit patient feedback on promising alternative communication formats to the hemoglobin A1C (A1C). In the second phase of the study, the investigators will test new formats to communicate information regarding diabetes control to patients with poorly controlled diabetes. This phase will be a three arm RCT comparing the effect of A1C (standard medical information) versus two alternative formats on several participant outcomes, primarily glycemic control at 6 months post-intervention.

Conditions Studied

Interventions

  • OTHER Phase II of the Study: Information regarding Current Diabetes Control

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2013-10
Est. Completion 2015-07
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01886170

The ClinicalTrials.gov registry entry for NCT01886170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Phase II of the Study: Information regarding Current Diabetes Control is the first listed.

NCT01886170 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01886170 about?

NCT01886170 is a clinical study titled "Using Patient Feedback to Improve Communication Regarding Glycemic Control to Patients With Diabetes". In this two-phase mixed methods study, the investigators will first use patient feedback from semi-structured interviews to explore the ways in which patients with diabetes understand their diabetes and assess their disease control. The investigators will also use these interviews to elicit patient ...

What is the current status of trial NCT01886170?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2013-10. Estimated completion is 2015-07.

What conditions does trial NCT01886170 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01886170?

The interventions under investigation include: Phase II of the Study: Information regarding Current Diabetes Control (OTHER).

Who is sponsoring clinical trial NCT01886170?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01886170 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.